Hiroaki Kiyokawa
About
Hiroaki Kiyokawa has authored 114 papers that have received a total of 7.5k indexed citations.
This includes 81 papers in Molecular Biology, 60 papers in Oncology and 22 papers in Cell Biology. The topics of these papers are Cancer-related Molecular Pathways (49 papers), Ubiquitin and proteasome pathways (26 papers) and Epigenetics and DNA Methylation (21 papers). Hiroaki Kiyokawa is often cited by papers focused on Cancer-related Molecular Pathways (49 papers), Ubiquitin and proteasome pathways (26 papers) and Epigenetics and DNA Methylation (21 papers) and collaborates with scholars based in United States, Japan and China. Hiroaki Kiyokawa's co-authors include Dipankar Ray, Andrew Koff, Jun Yin, David S. Moons and Norio Kôno and has published in prestigious journals such as Nature, Cell and New England Journal of Medicine.
In The Last Decade
Fields of papers published by Hiroaki Kiyokawa
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Hiroaki Kiyokawa
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kathleen Kelly Breakdown of academic impact, for papers by Larry M. Wahl Breakdown of academic impact, for papers by Charlie H. Goldsmith Breakdown of academic impact, for papers by Simo O. Pehkonen Breakdown of academic impact, for papers by Jan ter Schegget Breakdown of academic impact, for papers by Gary Klein Breakdown of academic impact, for papers by Cassandra L. Fraser Breakdown of academic impact, for papers by Bryan C. Carstens